Your browser doesn't support javascript.
loading
Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B.
Hayashi, Hidetoshi; Tsurutani, Junji; Satoh, Taro; Masuda, Norikazu; Okamoto, Wataru; Morinaga, Ryotaro; Terashima, Masaaki; Miyazaki, Masaki; Okamoto, Isamu; Nishida, Yukihiro; Tominaga, Shusei; Tokunaga, Yukihiko; Yamaguchi, Masahide; Sakamoto, Junichi; Nakayama, Takahiro; Nakagawa, Kazuhiko.
Affiliation
  • Hayashi H; Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Breast Cancer ; 20(2): 131-6, 2013 Apr.
Article in En | MEDLINE | ID: mdl-22124996
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Camptothecin / Receptor, ErbB-2 / Topoisomerase Inhibitors / Liver Neoplasms / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Camptothecin / Receptor, ErbB-2 / Topoisomerase Inhibitors / Liver Neoplasms / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Japan